Cristina Cristofoletti
Overview
Explore the profile of Cristina Cristofoletti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Primerano A, De Domenico E, Cianfarani F, De Luca N, Floriddia G, Teson M, et al.
Br J Dermatol
. 2024 May;
191(4):568-579.
PMID: 38820176
Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a blistering disease caused by mutations in the gene encoding type VII collagen (C7). RDEB is associated with fibrosis, which is responsible for...
2.
Cristofoletti C, Bresin A, Fioretti M, Russo G, Narducci M
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740513
Sézary syndrome (SS) is an aggressive variant of cutaneous t-cell lymphoma characterized by the accumulation of neoplastic CD4+ lymphocytes-the SS cells-mainly in blood, lymph nodes, and skin. The tumor spread...
3.
Picozza M, Cristofoletti C, Bresin A, Fioretti M, Sambucci M, Scala E, et al.
J Invest Dermatol
. 2022 May;
142(11):3009-3019.e9.
PMID: 35533722
Sézary syndrome (SS) is a rare and aggressive variant of cutaneous T-cell lymphoma. It is characterized by the copresence of CD4+ neoplastic lymphocytes, named Sezary cells, mainly in the blood,...
4.
Cristinziano G, Porru M, Lamberti D, Buglioni S, Rollo F, Amoreo C, et al.
J Hepatol
. 2021 Mar;
75(2):351-362.
PMID: 33741397
Background & Aims: About 15% of intrahepatic cholangiocarcinomas (iCCAs) express fibroblast growth factor receptor 2 (FGFR2) fusion proteins (FFs), usually alongside mutational inactivation of TP53, CDKN2A or BAP1. In FFs,...
5.
Grimsholm O, Piano Mortari E, Davydov A, Shugay M, Obraztsova A, Bocci C, et al.
Cell Rep
. 2020 Mar;
30(9):2963-2977.e6.
PMID: 32130900
Memory B cells (MBCs) epitomize the adaptation of the immune system to the environment. We identify two MBC subsets in peripheral blood, CD27 and CD27 MBCs, whose frequency changes with...
6.
Minafo Y, Del Padre M, Cristofoletti C, Caprini E, Perez M, Aranburu A, et al.
Genes Immun
. 2020 Feb;
21(2):131-135.
PMID: 32066891
Hepatitis C virus (HCV) causes B-cell lymphoproliferative disorders (LPDs) expressing stereotyped B-cell receptors (BCRs) endowed with rheumatoid factor (RF) activity and putatively recognizing the HCV E2 protein. To further untangle...
7.
Bresin A, Cristofoletti C, Caprini E, Cantonetti M, Monopoli A, Russo G, et al.
J Invest Dermatol
. 2019 Nov;
140(5):1045-1053.e6.
PMID: 31682844
The phosphoinositide 3-kinase(PI3K)/protein kinase B (AKT)/ mammalian target of rapamycin (mTOR) pathway is hyperactivated in many tumors, as well as in cutaneous T-cell lymphoma (CTCL), which includes the mycosis fungoides...
8.
Cristofoletti C, Bresin A, Caprini E, Russo G, Narducci M
Cell Cycle
. 2019 May;
18(11):1292-1294.
PMID: 31106661
Sezary Syndrome is an aggressive T-cell Lymphoma involving blood, skin and lymphonodes Involvement of the CXCR4-SDF1 has been previously shown. We here present evidence also of the involvement of B-arrestin...
9.
Cristofoletti C, Narducci M, Russo G
Chin Clin Oncol
. 2018 Dec;
8(1):2.
PMID: 30525758
Sezary syndrome (SS) is a primary cutaneous T-cell lymphoma (CTCL) characterized by erythroderma, lymphadenopathy and leukemic involvement of the peripheral blood. The high relapse rates and a poor prognosis complicate...
10.
Cristofoletti C, Bresin A, Picozza M, Picchio M, Monzo F, Helmer Citterich M, et al.
Leukemia
. 2018 Dec;
33(5):1231-1242.
PMID: 30518812
Sézary syndrome (SS) is a rare and aggressive variant of Cutaneous T-Cell Lymphoma characterized by neoplastic distribution mainly involving blood, skin, and lymph-node. Although a role of the skin microenvironment...